Publications by authors named "Kurt Quitzau"

Claim this Profile
P
Potential Drug Interactions between Recombinant Interleukin-2 and Direct Oral Anticoagulants: Indirect Evidence from In Vivo Animal Studies.
Seyed Hamidreza Mahmoudpour, Luca Valerio, Jonathan Douxfils, Charles E Mahan, Marius Jankowski, Kurt Quitzau

Hamostaseologie· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials.
Seyed Hamidreza Mahmoudpour, Marius Jankowski, Luca Valerio, Christian Becker, Christine Espinola-Klein, Kurt Quitzau

Sci Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study.
Frederikus A Klok, Walter Ageno, Stefano Barco, Harald Binder, Benjamin Brenner, Kurt Quitzau

Thromb Haemost· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial.
Stefano Barco, Mareike Lankeit, Harald Binder, Sebastian Schellong, Michael Christ, Kurt Quitzau

Thromb Haemost· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Follow-up after acute pulmonary embolism. A prospective non-interventional multi-center cohort study (FOCUS)].
Stavros V Konstantinides, Mareike Lankeit, Philipp Wild, Kurt Quitzau, Harald Binder

Dtsch Med Wochenschr· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trials.
Matthias Hermann, Dieter Fischer, Michael M Hoffmann, Theo Gasser, Kurt Quitzau

Atherosclerosis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
Renke Maas, Kurt Quitzau, Edzard Schwedhelm, Lukas Spieker, Wolf Rafflenbeul

Atherosclerosis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial.
Inder Anand, John McMurray, Jay N Cohn, Marvin A Konstam, Thomas Notter, Kurt Quitzau

Lancet· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis